Rosuvastatin Decreases Intestinal Fatty Acid Binding Protein (I-FABP), but Does Not Alter Zonulin or Lipopolysaccharide Binding Protein (LBP) Levels, in HIV-Infected Subjects on Antiretroviral Therapy

INTRODUCTION: Altered gastrointestinal (GI) barrier integrity and subsequent microbial translocation may contribute to immune activation in HIV infection. We have reported that rosuvastatin improved several markers of immune activation in HIV+ participants, but the effect of statin treatment on mark...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pathog Immun
Main Authors: Funderburg, Nicholas T., Boucher, Morgan, Sattar, Abdus, Kulkarni, Manjusha, Labbato, Danielle, Kinley, Bruce I., McComsey, Grace A.
Formato: Artigo
Idioma:Inglês
Publicado em: Pathogens and Immunity 2016
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4972492/
https://ncbi.nlm.nih.gov/pubmed/27500282
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.20411/pai.v1i1.124
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados